N-(4-fluorobenzyl)-N'-[3-(2-{[(2R,S)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}ethyl)phenyl]urea | 1185463-73-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N-(4-fluorobenzyl)-N'-[3-(2-{[(2R,S)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}ethyl)phenyl]urea
• 英文别名: 1-(4-Fluorobenzyl)-3-(3-(2-(2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino)ethyl)phenyl)urea；1-[(4-fluorophenyl)methyl]-3-[3-[2-[[2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]ethyl]phenyl]urea
• CAS: 1185463-73-3
• 化学式: C₂₇H₂₇FN₄O₄
• 分子量: 490.534
• InChiKey: REXUUKCAGPTANY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  36
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  123
• 氢给体数：
  6
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  间硝基氯化苄 在 盐酸 、 sodium tetrahydroborate 、 dimethyl sulfide borane 、 palladium 10% on activated carbon 、 氢气 、 三乙胺 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 二氯甲烷 、 水 、 二甲基亚砜 为溶剂， 20.0~95.0 ℃ 、206.85 kPa 条件下， 反应 47.5h， 生成 N-(4-fluorobenzyl)-N'-[3-(2-{[(2R,S)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}ethyl)phenyl]urea
  参考文献：
  名称：

  取代的苯基脲衍生物是新颖的发现长效β 2肾上腺素受体激动剂

  摘要：

  多样官能脲的以半平行的方式的合成所描述的，以及它们的β 1 /β 2 -肾上腺素能活动和相应的结构-活性关系（SAR）。我们专注于亲脂性和作用时间，并且我们发现了这一系列分子之间的强相关性。将提出定量结构-活性关系（QSAR）分析，以量化这种关系。

  DOI：

  10.1016/j.bmcl.2010.12.096

文献信息

• Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
  申请人：Laboratorios Almirall, S.A.

  公开号：EP2096105A1

  公开（公告）日：2009-09-02

  The present invention provides a compound of formula (I): wherein: R1 is a group selected from -CH2OH,-NHCOH and R2 is a hydrogen atom; or R1 together with R2 form the group -NHC(O)CH=CH-, wherein the nitrogen atom is bound to the carbon atom in the phenyl ring holding R1 and the carbon atom is bound to the carbon atom in the phenyl ring holding R2, R3a and R3b are independently selected from the group consisting of hydrogen atoms and C1-4 alkyl groups n is an integer selected from 0 to 6, R4 is selected from the group consisting of an optionally substituted monocyclic or polycyclic C3-10 cycloalkyl group, an optionally substituted monocyclic C5-10 aryl group and, a methyl group which is substituted with one or more substituents selected from C5-10 aryl and C5-10 aryloxy groups, wherein the monocyclic or polycyclic C3-10 cycloalkyl and the monocyclic C5-10 aryl groups independently are optionally substituted with one or more substituents selected from halogen atoms, C1-4 alkyl, C1-4 alkoxy, C5-10 aryl and C5-10 aryloxy groups, or a pharmaceutically-acceptable salt or solvate or stereoisomer thereof.

  本发明提供了一种化合物，其化学式为（I）：其中：R1是从-CH2OH，-NHCOH和R2是氢原子中选择的一个基团；或者R1与R2一起形成-NHC(O)CH=CH-基团，其中氮原子与持有R1的苯环中的碳原子结合，碳原子与持有R2的苯环中的碳原子结合，R3a和R3b分别从氢原子和C1-4烷基组成的基团中独立选择n是从0到6选择的整数，R4从可选择的经取代的单环或多环C3-10环烷基组、可选择的经取代的单环C5-10芳基组以及一个用一个或多个从C5-10芳基和C5-10芳氧基组中选择的取代基取代的甲基组中选择，其中单环或多环C3-10环烷基和单环C5-10芳基组可以独立地用一个或多个从卤原子、C1-4烷基、C1-4烷氧基、C5-10芳基和C5-10芳氧基组中选择的取代基取代，或其药用可接受的盐、溶剂或其立体异构体。
• DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
  申请人：Puig Duran Carlos

  公开号：US20110028442A1

  公开（公告）日：2011-02-03

  The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the β2 adrenergic receptor.

  本公开涉及公式（I）的4-（2-氨基-1-羟乙基）苯酚衍生物，以及包含它们的制药组合物，以及它们作为β2肾上腺素能受体激动剂在治疗中的使用。
• [EN] DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR<br/>[FR] DÉRIVÉS DE 4-(2-AMINO-1-HYDROXYÉTHYL)PHÉNOL COMME AGONISTES DU RÉCEPTEUR ADRÉNERGIQUE B2
  申请人：ALMIRALL SA

  公开号：WO2009106351A1

  公开（公告）日：2009-09-03

  The present invention provides a compound of formula (I): wherein: R1 is a group selected from -CH2OH1-NHCOH and R2 is a hydrogen atom; or R1 together with R2 form the group -NHC(O)CH=CH-, wherein the nitrogen atom is bound to the carbon atom in the phenyl ring holding R1 and the carbon atom is bound to the carbon atom in the phenyl ring holding R2, R3a and R3b are independently selected from the group consisting of hydrogen atoms and C1-4 alkyl groups n is an integer selected from O to 6, R4 is selected from the group consisting of an optionally substituted monocyclic or polycyclic C3-10 cycloalkyl group, an optionally substituted monocyclic C5-10 aryl group and, a methyl group which is substituted with one or more substituents selected from C5-1O aryl and C5-10 aryloxy groups, wherein the monocyclic or polycyclic C3-10 cycloalkyl and the monocyclic C5-10 aryl groups independently are optionally substituted with one or more substituents selected from halogen atoms, C1-4 alkyl, C1-4 alkoxy, C5-10 aryl and C5-10 aryloxy groups, or a pharmaceutically-acceptable salt or solvate or stereoisomer thereof.
• Discovery of substituted phenyl urea derivatives as novel long-acting β2-adrenoreceptor agonists
  作者：Daniel Pérez、Maribel Crespo、Laia Solé、Maria Prat、Carla Carcasona、Elena Calama、Raquel Otal、Amadeu Gavaldá、Mireia Gómez-Angelats、Montserrat Miralpeix、Carles Puig

  DOI：10.1016/j.bmcl.2010.12.096

  日期：2011.3

  The synthesis of diverse functionalized ureas in a semi-parallel fashion is described, as well as their β1/β2-adrenergic activities and the corresponding structure–activity relationship (SAR). We have focused on lipophilicity and duration of action, and we have discovered a strong correlation in this series of molecules. A quantitative structure–activity relationship (QSAR) analysis will be presented

  多样官能脲的以半平行的方式的合成所描述的，以及它们的β 1 /β 2 -肾上腺素能活动和相应的结构-活性关系（SAR）。我们专注于亲脂性和作用时间，并且我们发现了这一系列分子之间的强相关性。将提出定量结构-活性关系（QSAR）分析，以量化这种关系。